BioHiTech Global Inc. (NASDAQ: BHTG) is 45.98% higher on its value in year-to-date trading and has touched a low of $1.01 and a high of $4.40 in the current 52-week trading range. The BHTG stock was last observed hovering at around $1.33 in the last trading session, with the day’s gains setting it 0.3% off its average median price target of $2.50 for the next 12 months. It is also 45.67% off the consensus price target high of $3.00 offered by 2 analysts, but current levels are 18.5% higher than the price target low of $2.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $1.63, the stock is 34.96% and 30.14% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.97 million and changing 22.93% at the moment leaves the stock 17.35% off its SMA200. BHTG registered -13.49% loss for a year compared to 6-month loss of -19.85%. The firm has a 50-day simple moving average (SMA 50) of $1.2603 and a 200-day simple moving average (SMA200) of $1.4340.
The stock witnessed a 27.73% gain in the last 1 month and extending the period to 3 months gives it a 26.74%, and is 32.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.30% over the week and 6.53% over the month.
BioHiTech Global Inc. (BHTG) has around 39 employees, a market worth around $38.46M and $4.40M in sales. Distance from 52-week low is 61.88% and -62.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.60%).
BioHiTech Global Inc. (BHTG) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for BioHiTech Global Inc. (BHTG) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
BioHiTech Global Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $700k over the same period.The EPS is expected to grow by 49.90% this year, but quarterly earnings will post -3.30% year-over-year. Quarterly sales are estimated to shrink -30.40% in year-over-year returns.
BioHiTech Global Inc. (BHTG) Top Institutional Holders
19 institutions hold shares in BioHiTech Global Inc. (BHTG), with 5.19M shares held by insiders accounting for 22.22% while institutional investors hold 2.29% of the company’s shares. The shares outstanding are 22.05M, and float is at 18.17M with Short Float at 0.25%. Institutions hold 1.78% of the Float.
The top institutional shareholder in the company is Raymond James Financial Services Advisors, Inc. with over 0.12 million shares valued at $0.17 million. The investor’s holdings represent 0.80% of the BHTG Shares outstanding. As of Sep 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 87718.0 shares valued at $0.13 million to account for 0.59% of the shares outstanding. The other top investors are Steward Partners Investment Advisory, LLC which holds 55367.0 shares representing 0.37% and valued at over $80282.0, while Cetera Advisor Networks LLC holds 0.23% of the shares totaling 34636.0 with a market value of $50222.0.
BioHiTech Global Inc. (BHTG) Insider Activity
A total of 3 insider transactions have happened at BioHiTech Global Inc. (BHTG) in the last six months, with sales accounting for 0 and purchases happening 3 times. The most recent transaction is an insider purchase by CELLI FRANK E., the company’s Director. SEC filings show that CELLI FRANK E. bought 1,000 shares of the company’s common stock on Nov 24 at a price of $1.28 per share for a total of $1280.0. Following the purchase, the insider now owns 1.47 million shares.
BioHiTech Global Inc. disclosed in a document filed with the SEC on Nov 23 that CELLI FRANK E. (Director) bought a total of 1,250 shares of the company’s common stock. The trade occurred on Nov 23 and was made at $1.25 per share for $1566.0. Following the transaction, the insider now directly holds 1.47 million shares of the BHTG stock.
Still, SEC filings show that on Jul 02, Fuller Anthony (CHIEF ADMINSTRATIVE OFFICER) acquired 1,000 shares at an average price of $1.91 for $1910.0. The insider now directly holds 5,000 shares of BioHiTech Global Inc. (BHTG).